Site Map | Links | Contact Us
PROXINIUM TRIALS

A Global Phase II/III trial

Ages Eligible for Study:
18 Years and above,

Genders Eligible for Study:
Both

Inclusion Criteria (what you must have in order to enter the trial):

Disease Characteristics

  • You have squamous cell carcinoma of the head and neck
  • The cancer cells express the Ep-CAM molecule (which you will be tested for once you enter the trial)
  • Your have received therapy for the cancer but the cancer persisted or came back

Prior/Concurrent Therapy

  • It has been at least 2 weeks since the last dose of
    anti-cancer therapy or radiotherapy or 4 weeks since
    any investigational therapy and the first dose of the study drug

Patient Characteristics

  • ECOG score of 0, 1, 2 or 3.
  • No renal or hepatic disease

Other

  • Patients must not become pregnant while participating in this trial

Exclusion Criteria (reasons you will not be allowed to enter into the trial):

  • You are eligible to have surgery to treat your cancer
  • You are eligible to receive additional chemotherapy or radiation therapy to treat your cancer
  • You have a nasopharyngeal tumor
  • Your tumors are prone to bleeding
  • You are on a “blood thinning medication” and you can not stop taking the medication
  • Your cancer has spread to other parts of your body including to the brain.

 

 

 


Click below